PreprintAll rights reservedbioRxiv
ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections
- 1Cedars-Sinai Medical Center
Related
- Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020–2026
- Natural and engineered bacteriophages against multidrug-resistant ESKAPE pathogens: current landscape and clinical translation
- Optimizing Lavandula mairei-mediated silver nanoparticle synthesis for effective inhibition and eradication of multidrug-resistant bacterial biofilms
- Impact of Pharmacist-Involved Antimicrobial Stewardship Interventions on Clinical and Process Outcomes in Multidrug-Resistant Organism Infections: A Systematic Review and Meta-Analysis.
- Repurposing amlodipine, fluoxetine, and escitalopram as non-antibiotic adjuvants: in vitro enhancement of ciprofloxacin and fluconazole activity against multidrug-resistant bacterial and candida clinical isolates.
BibTeX
@misc{shibata2026aceengineered,
title = {{ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections}},
author = {T. Shibata and S. A. Bhat and S. Saito and T. B. Dar and B. GC and E. A. Bernstein and N. Khan and D. Sareen and H. S. Goodridge and W. G. Tourtellotte and K. E. Bernstein and Z. Khan},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.09.765250},
url = {https://www.biorxiv.org/content/10.64898/2026.11.09.765250v1},
}
RIS
TY - UNPB
TI - ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections
AU - T. Shibata
AU - S. A. Bhat
AU - S. Saito
AU - T. B. Dar
AU - B. GC
AU - E. A. Bernstein
AU - N. Khan
AU - D. Sareen
AU - H. S. Goodridge
AU - W. G. Tourtellotte
AU - K. E. Bernstein
AU - Z. Khan
PY - 2026
DA - 2026/11/09
PB - bioRxiv
DO - 10.64898/2026.11.09.765250
UR - https://www.biorxiv.org/content/10.64898/2026.11.09.765250v1
ER -